See the DrugPatentWatch profile for sapropterin
Sapropterin is a crucial enzyme in the synthesis of tetrahydrobiopterin (BH4), a cofactor essential for the production of neurotransmitters and the regulation of blood pressure. BH4 is synthesized from the amino acid phenylalanine through a series of enzyme-catalyzed reactions [1]. Sapropterin plays a central role in this process by catalyzing the conversion of 6-pyruvoyltetrahydropterin to tetrahydrobiopterin [2].
The synthesis of BH4 begins with the conversion of phenylalanine to 6-pyruvoyltetrahydropterin by the enzyme phenylalanine hydroxylase [3]. This intermediate is then converted to tetrahydrobiopterin through a series of enzyme-catalyzed reactions, including the step catalyzed by sapropterin [2]. The final product, tetrahydrobiopterin, is then used to synthesize neurotransmitters such as dopamine, norepinephrine, and serotonin [4].
Sapropterin deficiency has been linked to a range of disorders, including phenylketonuria (PKU), a genetic disorder characterized by an inability to metabolize phenylalanine [5]. In PKU, the accumulation of phenylalanine can lead to intellectual disability, seizures, and other neurological symptoms [6]. Treatment of PKU often involves dietary restriction of phenylalanine and supplementation with sapropterin [7].
In conclusion, sapropterin plays a critical role in the synthesis of tetrahydrobiopterin, a cofactor essential for neurotransmitter production and blood pressure regulation. Deficiencies in sapropterin can lead to disorders such as PKU, highlighting the importance of this enzyme in human health.
Sources:
[1] "Tetrahydrobiopterin biosynthesis" - Wikipedia
[2] "Sapropterin" - DrugPatentWatch.com
[3] "Phenylalanine hydroxylase" - ScienceDirect
[4] "Tetrahydrobiopterin" - ScienceDirect
[5] "Phenylketonuria" - MedlinePlus
[6] "Phenylketonuria" - Wikipedia
[7] "Phenylketonuria treatment" - Healthline
Note: The sources cited are a mix of reputable online sources, including Wikipedia, ScienceDirect, MedlinePlus, and Healthline.